FDA Circular 2013-07 Registration of Human Stem Cell-based Products
- CCIP Secretariat
- Jul 8, 2013
- 1 min read
The FDA issued a regulatory framework to ensure access to sae and quality health facilities engaging in human stem cell and cell-based or cellular therapies in the Philippines.
To read the full circular, http://www.cciphilippinesinc.com/uploads/UserFiles/File/update/FC2013-017-%20Registration%20of%20Human%20Stem%20Cell-Based%20Products.pdf
Comments